Search research articles
Contact Us
Filters
Showing results (551-560 of 565) with videos related to
Page
of 57
Sort By:
Cell Research
|
July 21, 2020
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
Yu-Pei Chen, Jian-Hua Yin, Wen-Fei Li, et al.
International Journal of Cancer
|
January 8, 2019
Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial
Wen-Fei Li, Nian-Yong Chen, Ning Zhang, et al.
Cancer Cell
|
January 19, 2024
Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma
Xiao-Jing Du, Gao-Yuan Wang, Xiao-Dong Zhu, et al.
The Lancet. Oncology
|
October 1, 2016
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
Ying Sun, Wen-Fei Li, Nian-Yong Chen, et al.
Lancet (London, England)
|
June 10, 2021
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
Yu-Pei Chen, Xu Liu, Qin Zhou, et al.
Nature Cancer
|
July 1, 2026
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study
Ya-Lan Tao, Dong-Hong Wu, Qin Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2022
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial
Yuan Zhang, Lei Chen, Guo-Qing Hu, et al.
Nature
|
March 12, 2026
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma
Jiawei Lv, Dan-Xue Zheng, Jin-Hui Liang, et al.
The New England Journal of Medicine
|
June 1, 2019
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
Yuan Zhang, Lei Chen, Guo-Qing Hu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 28, 2025
Chinese expert consensus on hematologic malignancy karyotyping
Zailin Yang, Shuang Chen, Mingyu Zhao, et al.
Page
of 57
Search research articles
Search
Showing results (551-560 of 565) with videos related to
Sort By:
Page
of 57
Cell Research
|
July 21, 2020
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
Yu-Pei Chen, Jian-Hua Yin, Wen-Fei Li, et al.
International Journal of Cancer
|
January 8, 2019
Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial
Wen-Fei Li, Nian-Yong Chen, Ning Zhang, et al.
Cancer Cell
|
January 19, 2024
Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma
Xiao-Jing Du, Gao-Yuan Wang, Xiao-Dong Zhu, et al.
The Lancet. Oncology
|
October 1, 2016
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
Ying Sun, Wen-Fei Li, Nian-Yong Chen, et al.
Lancet (London, England)
|
June 10, 2021
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
Yu-Pei Chen, Xu Liu, Qin Zhou, et al.
Nature Cancer
|
July 1, 2026
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study
Ya-Lan Tao, Dong-Hong Wu, Qin Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2022
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial
Yuan Zhang, Lei Chen, Guo-Qing Hu, et al.
Nature
|
March 12, 2026
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma
Jiawei Lv, Dan-Xue Zheng, Jin-Hui Liang, et al.
The New England Journal of Medicine
|
June 1, 2019
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
Yuan Zhang, Lei Chen, Guo-Qing Hu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 28, 2025
Chinese expert consensus on hematologic malignancy karyotyping
Zailin Yang, Shuang Chen, Mingyu Zhao, et al.
Page
of 57